14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Thu, 9 May 2024

Trading levels for ITRM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.64 2.68 %
R2 1.62 1.43 %
R1 1.61 0.663 %
Current price: 1.60
Support S1 1.57 -1.83 %
S2 1.56 -2.59 %
S3 1.54 -3.84 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.87 16.88 %
R2 1.67 4.37 %
R1 1.62 1.25 %
Current price 1.60
Support S1 1.58 -1.25%
S2 1.54 -3.75%
S3 1.49 -6.88%

ITRM Predictions History

3 years ago
JS predicted that ITRM for 2021-02-16 is going $2.19 (-3.10%)

3 years ago
FNLong predicted that ITRM for 2021-02-16 is going $1.97 (-12.83%)

Rank:

3 years ago
JS predicted that ITRM for 2021-02-12 is going $2.23 (-1.33%)

3 years ago
Dylan Foden predicted that ITRM for 2021-02-12 is going

Rank:

3 years ago
JS predicted that ITRM for 2021-02-11 is going $2.53 (7.66%)

3 years ago
GazzaDK predicted that ITRM for 2021-02-11 is going

Rank:

3 years ago
JS predicted that ITRM for 2021-01-26 is going $1.74 (10.13%)

3 years ago
JS predicted that ITRM for 2021-01-21 is going $1.66 (-14.87%)

3 years ago
nsquishee predicted that ITRM for 2021-01-21 is going $2.50 (28.21%)

Rank:

3 years ago
JS predicted that ITRM for 2020-12-21 is going $0.87 (-11.26%)

Click to get the best stock tips daily for free!

About Iterum Therapeutics Plc

Iterum Therapeutics Plc Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company ... ITRM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT